Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA(Leu) gene (m.3243A>G)

Journal of Inherited Metabolic Disease

Volumn 31, Issue , 2008, Pages 497-503

  Sproule, D M ^a   Dyme, J ^b   Coku, J ^a   de Vinck, D ^a   Rosenzweig, E ^a   Chung, W K ^a   De Vivo, D C ^a  

^a NewYork Presbyterian Hospital   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84977577844     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0735-3     Document Type: Review

References (31)

1. Anan R, Nakagawa M, Miyata M, et al (1995) Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation91(4): 955–961.
2. Barclay AR, Sholler G, Christodolou J, et al (2005) Pulmonary hypertension—a new manifestation of mitochondrial disease. J Inherit Metab Dis28: 1081–1089.
3. Bonnet S, Michelakis ED, Porter CJ, et al (2006) An abnormal mitochondrial–hypoxia inducible factor-1–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats; similarities to human pulmonary arterial hypertension. Circulation113: 2630–2641.
4. DiMauro S, Hirano M, Schon EA, eds. (2006a) Mitochondrial Medicine. Abingdon, UK: Informa Healthcare.
5. DiMauro S, Hirano M, Schon EA (2006b) Approaches to the treatment of mitochondrial diseases. Muscle Nerve34(3): 265–283.
6. Driessen J, Willems S, Dercksen S, et al (2007) Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Pediatr Anesth17(1): 16–21.
7. Hirano M, Pavlakis SG (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol9(1): 4–13.
8. Hirano M, Ricci E, Koenigsberger MR (1992) Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord2(2): 125–135.
9. Hsieh RH, Li JY, Pang CY, et al (2001) A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy. J Biomed Sci8(4): 328–335.
10. Jaksch M, Hofmann S, Kaufhold P, et al (1996) A novel combination of mitochondrial tRNA and ND1 gene mutations in a syndrome with MELAS, cardiomyopathy, and diabetes mellitus. Hum Mutat7(4): 358–360.
11. Kaufmann P, Engelstad K, Wei Y, et al (2006) Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology66(3): 324–330.
12. Koga Y, Akita Y, Junko N, et al (2006) Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology66: 1766–1769.
13. Manouvrier S, Rotig A, Hannebique G, et al (1995) Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J Med Genet32(8): 654–656.
14. McMurtry SM, Bonnet S, Wu X, et al (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res95: 830–840.
15. Morris CR, Morris SM, Hagar W, et al (2003) Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease. Am J Respir Care Med168: 63–69.
16. Naini A, Kaufmann P, Shanske S, et al (2005) Hypocitrullinemia in patients with MELAS: an insight into the ‘MELAS paradox’. J Neurol Sci229–230: 187–193.
17. Okajima Y, Tanabe M, Takayanagi H, et al (1998) A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart80: 292–295.
18. Pavlakis SG, Phillips PC, DiMauro S, et al (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol16(4): 481–488.
19. Rich S, Dantzker DR, Ayres SM, et al (1987) Primary pulmonary hypertension: a national prospective study. Ann Intern Med107: 216–223.
20. Roberts JD Jr, Fineman JR, Morin FC, et al (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med336(9): 605–610.
21. Sato W, Tanaka M, Sugiyama S, et al (1994) Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am Heart J128(4): 733–741.
22. Shipton EA, Prosser DO (2004) Mitochondrial myopathies and anaesthesia. Eur J Anaesthesiol21: 173–178.
23. Silvestri G, Bertini E, Servidei S, et al (1997) Maternally inherited cardiomyopathy: a new phenotype associated with the A to G at nt.3243 of mitochondrial DNA (MELAS mutation). Muscle Nerve20(2): 221–225.
24. Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, De Vivo DC (2007) Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol64(11): 1625–1627.
25. Thorburn DR (2004) Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis27(3): 349–362.
26. Venditti CP, Harris MC, Huff D, et al (2004) Congenital cardiomyopathy and pulmonary hypertension: another fatal variant of cytochrome-c oxidase deficiency. J Inherit Metab Dis27(6): 735–739.
27. Vilarinho L, Santorelli FM, Rosas MJ, et al (1997) The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet34(7): 607–609.
28. Vosatka RJ, Kashyap S, Trifiletti RR (1994) Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate66(2–3): 65–70.
29. Waypa GB, Schumacker PT (2005) Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. Appl Physiol98: 404–414.
30. Xu W, Kaneko FT, Zheng S, et al (2004) Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J18(14): 1746–1748.
31. Zeviani M, Gellera C, Antozzi C, et al (1991) Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet338(8760): 143–147.